By Tom Hals
(Reuters) – Bayer AG won its first trial over claims its Roundup weedkiller causes cancer after a California jury found that the herbicide was not a substantial cause of a child's rare form of non-Hodgkin's lymphoma, the company said on Tuesday.
Destiny Clark alleged that her son Ezra developed Burkitt's lymphoma after he was exposed to Roundup which she sprayed on weeds at the family residence.
Clark sued Monsanto, which is owned by Bayer, for failing to warn her of the cancer risks of using Roundup.
The verdict is the fourth involving Roundup and the first in the company's favor.
Roundup-related lawsuits have dogged Bayer since it acquired the brand as part of its $63 billion purchase of agricultural seeds and pesticides maker Monsanto in 2018.
Bayer said in a statement the verdict was consistent with decades of science and research showing the safety of glyphosate, the main ingredient in Roundup.
"While we have great sympathy for Ezra Clark and his family, the jury carefully considered the science applicable to this case and determined that Roundup was not the cause of his illness," the company said.
An attorney for Clark said they will consider an appeal.
"We're disappointed for the boy and his family," said Fletcher Trammel. "We have multiple Roundup cases set across the country over the next year and look forward to trying them."
Two of the other three verdicts are still being appealed by Bayer, including one the company hopes will be considered by the U.S. Supreme Court, where a ruling for Bayer could effectively end the Roundup cases.
The company has settled around 96,000 Roundup cases of about 125,000.
In May, a federal judge rejected Bayer's plan to resolve future cases, which would have provided compensation but limited the ability of individuals to sue.
(Reporting by Tom Hals in Wilmington, Delaware; Editing by Noeleen Walder and Richard Pullin)
In July 2020, Geiger was diagnosed with a rare form of Non-Hodgkin's lymphoma.
MEXICO CITY (Reuters) -Bayer is evaluating its legal options after Mexican health regulators for the first time rejected a GMO corn permit it was seeking, the German pharmaceutical and crop science giant said in a statement to Reuters on Friday, blasting the decision as "unscientific." Reuters reported earlier in the day that regulator Cofepris rejected the corn permit for future import as the government of President Andres Manuel Lopez Obrador hardens its opposition to genetically modified crops. "We are disappointed with the unscientific reasons that Cofepris used to deny the authorization," the statement said, identifying the rejected corn variety as using its proprietary HT3 x SmartStax Pro technology.
U.S. pesticide and seed maker Corteva Inc will take up to three times longer to break into Brazil's genetically modified soy seed market than it did in the United States, where Corteva's sales grew rapidly in recent years, the company said. Corteva is launching new genetically modified (GMO) soy seeds in top soybean grower Brazil, where rival Bayer AG has enjoyed a virtual monopoly since planting of GMOs began in the early 2000s.
“My hope in sharing is that we all become more educated, more familiar with what cancer looks like,” Shannen Doherty wrote for Breast Cancer Awareness Month.
Visiting the farmers' market is a great place to start, but there's more you can do.
Every year, in September-November, farmers in India's northern Punjab and Haryana states burn off the crop straw and stubble in preparation for the sowing season. After harvesting rice, farmers get a short window to plant winter crops such as wheat and rapeseed and late sowing means lower yields.The cost of disposing of the crop residue is high which makes them opt for stubble burning instead.The fields were filled with huge amount of smoke as farmers burnt stubble despite efforts by authorities to convince them to not burn crop residue.The smoke from fields combines with urban pollution from industrial emissions and vehicle exhaust and brings a sharp spike in pollution. Every winter, a thick blanket of smog settles over northern India, including the capital New Delhi, shutting schools and banning construction.
“Bumpitrage” occurs when activists push would-be acquirers to sweeten their offers for targets. It looks to become more prominent in the coming season.
Oct.08 — "Bloomberg Markets: Americas" with Alix Steel and Guy Johnson welcomed Elise Gould, Economic Policy Institute Senior Economist, to discuss the jobs report which came in well under estimates.
Horizon Acquisition Corporation (ticker: HZAC) merging with Vivid Seats in SPAC deal Ticker will automatically flip from HZAC to SEAT and trade on Nasdaq after deal closes later in October Vivid Seats offers secondary market for ticket buyers and sellers, taking a fee from each sale Company swung back to profits earlier in 2021 as […]
U.S. stocks dipped on Friday after data showed jobs growth in September was weaker than expected, yet investors still expected the Federal Reserve to begin tapering asset purchases this year. This exerted pressure on the S&P 500 and Nasdaq, which went into negative territory. Most of the 11 major S&P sectors fell, with real estate and materials the deepest decliners, each down about 0.6%.
Canadian marijuana stocks have fallen from their February highs. But one player in the industry got a lot bigger after a merger deal.
The new CFO joins the Denver-based ed tech giant at a time when it is seeing significant growth helping companies retain employees through education and upskilling programs.
When the UK’s annual gender pay gap numbers come out there’s always the possibility of a dramatic change showing up in the data. HSBC Bank Plc, an entity which employs 2,000 people in the UK and includes HSBC’s global banking and markets business, has the biggest gender pay gap, at 54% in 2020-21, meaning that women earn just 46 pence for every £1 men earn. HSBC UK, meanwhile, which contains the company’s UK retail banking operations and employs upwards of 20,000 people, has a less pronounced gap, but still over 30%.
(Bloomberg) — Most Read from BloombergNYC's Waldorf Gets Plush Renovation, Becomes Icon of China's OverreachTycoon Behind a Crisis-Era Property Crash Now Sits on a $9 Billion Debt MountainBefore Interstates, America Got Around on InterurbansHow Singapore's $50 Billion Financial District Will Change After Covid-19Amazon Delivery Partners Rage Against the Machines: ‘We Were Treated Like Robots’A BlackRock Inc. decision to give some of its biggest clients more power to vote at shareholder meetings
(Bloomberg) — U.S. stocks fell and Treasury yields gained Friday after weak jobs data upended bets on the Federal Reserve’s policy plans.Most Read from BloombergNYC's Waldorf Gets Plush Renovation, Becomes Icon of China's OverreachTycoon Behind a Crisis-Era Property Crash Now Sits on a $9 Billion Debt MountainBefore Interstates, America Got Around on InterurbansHow Singapore's $50 Billion Financial District Will Change After Covid-19Amazon Delivery Partners Rage Against the Machines: ‘We Were T
(Bloomberg) — Momentive Global Inc., the owner of SurveyMonkey, is exploring options including a potential sale after receiving takeover interest, according to people familiar with the matter.Most Read from BloombergNYC's Waldorf Gets Plush Renovation, Becomes Icon of China's OverreachTycoon Behind a Crisis-Era Property Crash Now Sits on a $9 Billion Debt MountainBefore Interstates, America Got Around on InterurbansHow Singapore's $50 Billion Financial District Will Change After Covid-19Amazon
Learn more about the relative strength index (RSI), which is used to indicate temporary overbought or oversold conditions, and its forex applications.
Gainers eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) rose 25.5% to $14.41 in pre-market trading after the company, in collaboration with investigators at Baylor College of Medicine, announced the presentation of new data for zotatifin in animal models of triple-negative breast cancer at the 2021 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. Camber Energy, Inc.. (NYSE: CEI) rose 19.7% to $2.13 in pre-market trading after jumping around 96% on Thursday. Immuro
Nothing like a little October turbulence to help the stock market’s weak hands get in touch with their inner bears. Momentum stocks tend to be strongest in the last couple of months of the year and weakest in January.
The stock markets succumbed to increased volatility in September, dragging down some of the best mutual funds and ETFs gains in Q3.
By Tom Hals